These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10885825)

  • 21. Antimicrobial susceptibility of bifidobacteria.
    Lim KS; Huh CS; Baek YJ
    J Dairy Sci; 1993 Aug; 76(8):2168-74. PubMed ID: 8408866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.
    Spencer RC
    Scand J Infect Dis Suppl; 1993; 91():25-32. PubMed ID: 8290900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro interaction between ofloxacin and cefotaxime against gram-positive and gram-negative bacteria involved in serious infections.
    Gimeno C; Borja J; Navarro D; Valdés L; García-Barbal J; García-de-Lomas J
    Chemotherapy; 1998; 44(2):94-8. PubMed ID: 9551238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility of pathogens isolated from more than 10,000 patients with infectious respiratory diseases: a 25-year longitudinal study.
    Goto H; Shimada K; Ikemoto H; Oguri T;
    J Infect Chemother; 2009 Dec; 15(6):347-60. PubMed ID: 20012724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antibiotics of the phosphonic acid group].
    Poliak MS
    Antibiot Med Biotekhnol; 1987 Jan; 32(1):66-75. PubMed ID: 3551820
    [No Abstract]   [Full Text] [Related]  

  • 26. Surveillance and management of multidrug-resistant microorganisms.
    Orsi GB; Falcone M; Venditti M
    Expert Rev Anti Infect Ther; 2011 Aug; 9(8):653-79. PubMed ID: 21819331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of microbiological reports on physician's choice of antimicrobial treatment for susceptible pathogens.
    Cobo J; Oliva J; Sanz J; Aguado JM; Del Pozo JL; Moreno S
    Eur J Clin Microbiol Infect Dis; 2003 Sep; 22(9):569-72. PubMed ID: 12938003
    [No Abstract]   [Full Text] [Related]  

  • 28. Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial.
    Morfin-Otero R; Noriega ER; Dowzicky MJ
    Ann Clin Microbiol Antimicrob; 2015 Dec; 14():53. PubMed ID: 26667651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacterial and fungal meningitis and antimicrobial susceptibility pattern in Tikur Anbessa University Hospital, Addis Ababa, Ethiopia.
    Mengistu M; Asrat D; Woldeamanuel Y; Mengistu G
    Ethiop Med J; 2011 Oct; 49(4):349-59. PubMed ID: 23409400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of ertapenem: review of recent studies.
    Wexler HM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in antimicrobial resistance among today's bacterial pathogens.
    Thornsberry C
    Pharmacotherapy; 1995; 15(1 Pt 2):3S-8S. PubMed ID: 7753690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [sensitivity of bacteria to chemotherapeutic agents (Zurich, 1993)].
    Wüst J; Kayser FH
    Praxis (Bern 1994); 1995 Jan; 84(4):98-105. PubMed ID: 7846439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2-Hydroxyisocaproic acid (HICA): a new potential topical antibacterial agent.
    Sakko M; Tjäderhane L; Sorsa T; Hietala P; Järvinen A; Bowyer P; Rautemaa R
    Int J Antimicrob Agents; 2012 Jun; 39(6):539-40. PubMed ID: 22483561
    [No Abstract]   [Full Text] [Related]  

  • 35. Incidence of beta-lactamase production among out patient clinical isolates in Middle Eastern countries and their antibiotic susceptibilities. Middle Eastern Study Group.
    Shibl AM
    Chemotherapy; 1992; 38(5):324-9. PubMed ID: 1286574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Nationwide sensitivity surveillance of ciprofloxacin and various parenteral antibiotics against bacteria isolated from patients with severe infections--the first Ciproxan IV special investigation in 2001].
    Yamaguchi K; Ishii Y; Iinuma Y; Yamanaka K; Ichiyama S; Watanabe N; Uehara N; Kaku M; Kurokawa Y; Hayashi M; Hirakata Y
    Jpn J Antibiot; 2003 Dec; 56(6):546-73. PubMed ID: 15007872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacterial pathogens (non-Mycobacterium) from sputum culture and antimicrobial susceptibility.
    Srifuengfung S; Sangsawang M; Komolpis P; Dhiraputra C; Chompanee B
    Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):96-9. PubMed ID: 9740278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
    Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
    [No Abstract]   [Full Text] [Related]  

  • 39. Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance.
    Lee SY; Kuti JL; Nicolau DP
    Surg Infect (Larchmt); 2005; 6(3):283-95. PubMed ID: 16201938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ANTIBIOTIC SUSCEPTIBILITY OF ORGANISMS CAUSING URINARY TRACT INFECTION IN PATIENTS PRESENTING AT KENYATTA NATIONAL HOSPITAL, NAIROBI.
    Magale HI; Kassim IA; Odera SA; Omolo MJ; Jaoko WG; Jolly PE
    East Afr Med J; 2015 Jul; 92(7):333-337. PubMed ID: 27867208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.